Faculty profile

Galit Kleiner

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Toronto

Galit Kleiner

Assistant Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
11 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

143

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Paratonia in Advanced Dementia: A Frequently Misunderstood Movement Disorder
Journal of the American Medical Directors Association · 2026 · senior author
Development of a Preliminary Collaborative Action Plan (CAP) for Care-Interfering Paratonia Using the Minimum Data Set (MDS) 2.0: A Pilot Study
Journal of the American Medical Directors Association · 2026 · first author
Diurnal-Only Foslevodopa/Foscarbidopa.
Movement disorders clinical practice · 2026

All 15 publications

15 publications.

Paratonia in Advanced Dementia: A Frequently Misunderstood Movement Disorder

Perri G-A, Hobbelen H, Cuppage J, Naglie G, Feldman S, Khan O, Ismail F, Boulias C, Kleiner G

Journal of the American Medical Directors Association20262 citationsSenior authorOpen Access

DOI: 10.1016/j.jamda.2026.106284

Development of a Preliminary Collaborative Action Plan (CAP) for Care-Interfering Paratonia Using the Minimum Data Set (MDS) 2.0: A Pilot Study

Kleiner G, Ismail F, Khan O, Boulias C, Harrylal S, Jing R, Cuppage J, Feldman S, Turcotte L, Nova A

Journal of the American Medical Directors Association2026First authorOpen Access

DOI: 10.1016/j.jamda.2026.106426

Diurnal-Only Foslevodopa/Foscarbidopa.

McGuckin A, Poon YY, Kleiner G, Fasano A

Movement disorders clinical practice2026

DOI: 10.1002/mdc3.70567 PMID: 41704070

Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management.

Kleiner G, Ganos C, Lang AE

Movement disorders clinical practice2026First author

DOI: 10.1002/mdc3.70836 PMID: 42775623

Surmountable Caregiver Barriers to Paratonia Treatment in Community-Dwellers with Dementia: A Cross-Sectional Survey.

Kleiner G, Cuppage J, Shnall A, Flick G, Omonibo S, Perri G

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2026First author

DOI: 10.1017/cjn.2026.10687 PMID: 42788218

Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle Resistance.

Kleiner G, Lang AE

Journal of the American Medical Directors Association2026First author

DOI: 10.1016/j.jamda.2026.106285 PMID: 42257639

Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study.

Klepitskaya O, LeWitt PA, Kilbane C, Seeberger LC, Isaacson SH, Gil R, Drake RS, Kleiner G, Stebbins GT, Serbin M, Brigas HC, Ramos D, Rattana S, Trotter J, Liang G

Clinical parkinsonism & related disorders2026

DOI: 10.1016/j.prdoa.2026.100435 PMID: 42016531

Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights

Kleiner G, Ismail F, Khan O, Pilieci C, Truong L, Boulias C

Canadian Journal of Neurological Sciences20254 citationsFirst authorOpen Access

DOI: 10.1017/cjn.2024.46

Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.

Kon T, Ichimata S, Di Luca DG, Martinez-Valbuena I, Kim A, Yoshida K, Alruwaita AA, Kleiner G, Strafella AP, Forrest SL, Sato C, Rogaeva E, Fox SH, Lang AE, Kovacs GG

Brain communications202412 citationsOpen Access

DOI: 10.1093/braincomms/fcae141 PMID: 38712319

Case of a Man with Hemichorea and Behavioral Changes: "A Red Herring".

Kleiner G, Ryan SA, Bilbao J, Keith J, Rogaeva E, Black SE, Lang AE, Masellis M

Movement disorders clinical practice20222 citationsFirst authorOpen Access

DOI: 10.1002/mdc3.13433 PMID: 35586540

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Galit Kleiner

Research

Latest papers

Paratonia in Advanced Dementia: A Frequently Misunderstood Movement Disorder

Development of a Preliminary Collaborative Action Plan (CAP) for Care-Interfering Paratonia Using the Minimum Data Set (MDS) 2.0: A Pilot Study

Diurnal-Only Foslevodopa/Foscarbidopa.

Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management.

Surmountable Caregiver Barriers to Paratonia Treatment in Community-Dwellers with Dementia: A Cross-Sectional Survey.

Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle Resistance.

Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study.

Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights

Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.

Case of a Man with Hemichorea and Behavioral Changes: "A Red Herring".

Frequent collaborators

Omar Khan

Mario Masellis

Ekaterina Rogaeva

Chris Boulias

Farooq Ismail

Julia Keith

Alfonso Fasano

Sandra Black

Sid Feldman

Susan Fox

I. Naglie

Sean Udow

Connie Marras

Philip Saleh

Tiago Mestre

Adriana Shnall

Gary Naglie

Christos Ganos

Luke Turcotte

Gabor Kovacs

Galit Kleiner

Research

Latest papers

Paratonia in Advanced Dementia: A Frequently Misunderstood Movement Disorder

Development of a Preliminary Collaborative Action Plan (CAP) for Care-Interfering Paratonia Using the Minimum Data Set (MDS) 2.0: A Pilot Study

Diurnal-Only Foslevodopa/Foscarbidopa.

Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management.

Surmountable Caregiver Barriers to Paratonia Treatment in Community-Dwellers with Dementia: A Cross-Sectional Survey.

Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle Resistance.

Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study.

Survey of Canadian Physician Use of Botulinum Toxin A (BoNT-A) for Paratonia: Real World Insights

Multiple system atrophy with amyloid-&#x3b2;-predominant Alzheimer's disease neuropathologic change.

Case of a Man with Hemichorea and Behavioral Changes: "A Red Herring".

Frequent collaborators

Omar Khan

Mario Masellis

Ekaterina Rogaeva

Chris Boulias

Farooq Ismail

Julia Keith

Alfonso Fasano

Sandra Black

Sid Feldman

Susan Fox

I. Naglie

Sean Udow

Connie Marras

Philip Saleh

Tiago Mestre

Adriana Shnall

Gary Naglie

Christos Ganos

Luke Turcotte

Gabor Kovacs

Multiple system atrophy with amyloid-β-predominant Alzheimer's disease neuropathologic change.